Emerald Health Therapeutics (CVE:EMH) Shares Down 3.8%

Emerald Health Therapeutics, Inc. (CVE:EMH)’s share price fell 3.8% on Wednesday . The company traded as low as C$0.25 and last traded at C$0.26. 384,329 shares traded hands during trading, a decline of 40% from the average session volume of 644,760 shares. The stock had previously closed at C$0.27.

The business has a 50-day simple moving average of C$0.26. The company has a debt-to-equity ratio of 35.45, a current ratio of 2.97 and a quick ratio of 2.61. The firm has a market capitalization of C$52.28 million and a PE ratio of -0.37.

Emerald Health Therapeutics (CVE:EMH) last announced its quarterly earnings results on Monday, May 31st. The company reported C($0.01) earnings per share for the quarter. The company had revenue of C$2.26 million for the quarter. Equities analysts expect that Emerald Health Therapeutics, Inc. will post -0.21 EPS for the current fiscal year.

About Emerald Health Therapeutics (CVE:EMH)

Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.

Recommended Story: Channel Trading

Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.